ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

39,493Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 161

$1.9M Total Retail Price of All Prescriptions

Rank: 2 out of 161

879 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 879 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

29% of this provider’s 879 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 29,170 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 4%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $85 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,649 968 S3 1 1
LEVOTHYROXINE SODIUM 1,453 1,181 2 11
FUROSEMIDE 1,239 980 3 5
SIMVASTATIN 1,205 961 4 2
OMEPRAZOLE 1,139 870 5 4
POTASSIUM CHLORIDE 1,068 846 6 9
MELOXICAM 808 645 7 24
LISINOPRIL 779 572 8 3
AMLODIPINE BESYLATE 776 602 9 6
GABAPENTIN 736 506 10 10
WARFARIN SODIUM 671 567 11 12
METOPROLOL TARTRATE 670 541 12 7
METFORMIN HCL 663 467 13 19
CITALOPRAM HBR 645 467 14 29
FAMOTIDINE 605 475 15 80
NEXIUM 547 343 16 22
SERTRALINE HCL 505 405 17 37
ZOLPIDEM TARTRATE 498 307 18 20
PRAVASTATIN SODIUM 480 394 19 15
CARVEDILOL 467 372 20 8
HYDROCHLOROTHIAZIDE 427 327 21 18
POLYETHYLENE GLYCOL 3350 413 340 22 61
ATENOLOL 386 274 23 26
ISOSORBIDE MONONITRATE ER 354 282 24 16
TAMSULOSIN HCL 340 255 25 23
CARISOPRODOL 339 86 R 26 48
TRAMADOL HCL 327 235 27 28
CYMBALTA 301 187 28 41
CLOPIDOGREL 299 269 29 13
METOPROLOL SUCCINATE 298 232 30 14
GLIPIZIDE 289 192 31 59
AZITHROMYCIN 282 186 32 97
NAMENDA 268 256 33 40
CLONIDINE HCL 258 184 34 44
PROMETHAZINE HCL 244 94 R 35 81
DONEPEZIL HCL 243 243 36 36
ATORVASTATIN CALCIUM 237 207 37 21
LOSARTAN POTASSIUM 233 186 38 31
MIRTAZAPINE 231 185 39 49
PLAVIX 217 202 40 17
ALLOPURINOL 197 184 41 66
RANITIDINE HCL 190 149 42 38
RISPERIDONE 186 166 43 111
TIZANIDINE HCL 182 93 44 58
CYCLOBENZAPRINE HCL 180 75 R 45 53
TRIAMTERENE-HCTZ 180 149 45 55
PREDNISONE 180 134 45 69
GLIPIZIDE ER 170 137 48 94
LEVOFLOXACIN 169 121 49 118
SUCRALFATE 168 114 50 73
CIPROFLOXACIN HCL 165 124 51 39
FENTANYL 165 104 S2 51 90
VERAPAMIL ER 164 151 53 132
FLUTICASONE PROPIONATE 162 129 54 43
PANTOPRAZOLE SODIUM 162 118 54 51
ESCITALOPRAM OXALATE 161 108 56 74
DOXYCYCLINE HYCLATE 159 92 57 100
OXYCODONE-ACETAMINOPHEN 156 108 S2 58 123
LYRICA 152 100 59 79
METOCLOPRAMIDE HCL 151 102 60 88
DILTIAZEM ER 149 131 61 117
JANTOVEN 148 117 62 226
ROPINIROLE HCL 147 121 63 92
ENABLEX 146 124 64 228
AMITRIPTYLINE HCL 145 76 R 65 45
CARBIDOPA-LEVODOPA 144 140 66 33
DIOVAN 142 120 67 50
TORSEMIDE 141 108 68 84
TRAZODONE HCL 139 82 69 35
GLIPIZIDE XL 139 127 69 146
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 116 69 30
LAMOTRIGINE 138 91 72 70
AMLODIPINE BESYLATE-BENAZEPRIL 134 73 73 112
KLOR-CON M20 132 103 74 103
ALENDRONATE SODIUM 129 109 75 68
DILTIAZEM HCL 124 104 76 245
SOTALOL 123 122 77 60
QUETIAPINE FUMARATE 121 104 78 109
FLUOXETINE HCL 119 43 79 87
EVISTA 119 95 79 150
BENAZEPRIL HCL 119 79 79 164
LOSARTAN-HYDROCHLOROTHIAZIDE 116 115 82 52
LANTUS 116 89 82 114
METHYLPREDNISOLONE 115 90 84 96
ETODOLAC 115 92 84 250
PROPRANOLOL HCL 115 102 84 138
BUSPIRONE HCL 114 97 87 152
KLOR-CON M10 106 92 88 178
RAMIPRIL 104 82 89 72
ABILIFY 104 50 89 115
SULFAMETHOXAZOLE-TRIMETHOPRIM 104 63 89 62
NITROFURANTOIN MONO-MACRO 104 86 89 191
TERAZOSIN HCL 103 84 93 151
PREMARIN 100 55 R 94 82
DIVALPROEX SODIUM 99 70 95 193
DIGOXIN 97 91 96 25
FLUDROCORTISONE ACETATE 96 80 97 270
VENLAFAXINE HCL 95 67 98 152
CRESTOR 91 62 99 34
SINGULAIR 90 47 100 119
ENALAPRIL MALEATE 89 83 101 106
DEXILANT 88 54 102 148
DETROL LA 84 83 103 167
LANTUS SOLOSTAR 84 51 103 190
PAROXETINE HCL 83 53 105 124
PRAMIPEXOLE DIHYDROCHLORIDE 83 62 105 107
CELEBREX 81 57 107 189
AMIODARONE HCL 80 79 108 42
LOVASTATIN 80 73 108 78
LUNESTA 80 78 108 284
NIFEDIPINE ER 79 55 111 83
METHOTREXATE 78 42 112 286
SPIRONOLACTONE 76 44 113 57
FLUCONAZOLE 76 43 113 176
MECLIZINE HCL 76 68 113 183
OXYBUTYNIN CHLORIDE ER 76 51 113 205
GLYBURIDE 76 67 R 113 196
DIOVAN HCT 75 54 118 65
VENLAFAXINE HCL ER 75 24 118 128
OLANZAPINE 75 31 118 184
CEPHALEXIN 74 62 121 131
FENOFIBRATE 72 60 122 95
FINASTERIDE 72 63 122 64
PROAIR HFA 71 33 124 71
PEN NEEDLE 71 50 124 199
AGGRENOX 70 70 126 215
CALCITONIN-SALMON 67 61 127 300
ALBUTEROL SULFATE 67 57 127 239
JANUVIA 67 55 127 172
TRIAMCINOLONE ACETONIDE 66 51 130 110
LIDODERM 66 43 130 237
BUPROPION XL 66 47 130 144
LIPITOR 65 51 133 128
OXYBUTYNIN CHLORIDE 64 48 134 136
NYSTATIN 63 39 135 226
AMOX TR-POTASSIUM CLAVULANATE 62 43 136 127
DOXAZOSIN MESYLATE 61 42 137 76
TRICOR 59 38 138 166
BUPROPION HCL SR 58 28 139 234
OXYCODONE HCL 57 33 S2 140 27
VESICARE 56 55 141 143
INSULIN SYRINGE 56 44 141 130
LEXAPRO 55 43 143 324
TOPIRAMATE 55 19 143 54
EXELON 55 45 143 160
ACYCLOVIR 55 11 143 160
NITROSTAT 54 32 147 77
SPS 54 23 147 327
OXYCODONE HCL-ACETAMINOPHEN 53 20 S2 149 99
NOVOLIN 70-30 53 20 149 331
COMBIVENT 53 17 149 181
GLIMEPIRIDE 52 51 152 113
DIVALPROEX SODIUM ER 51 30 153 104
MONTELUKAST SODIUM 50 22 154 162
GEMFIBROZIL 50 44 154 197
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.